Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C

Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C

Saved in:

Bibliographic Details
Main Authors:	Hwajeong Lee, Sanaz Ainechi, Karen Dresser, Elizabeth M. Kurian
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	International Journal of Hepatology
Online Access:	http://dx.doi.org/10.1155/2014/329297
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
by: Stefania Bruno, et al.
Published: (2019-01-01)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
by: Idilio Zamin, et al.
Published: (2002-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
by: S. Gitto, et al.
Published: (2015-01-01)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
by: Murat Kiyici, et al.
Published: (2003-01-01)

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
by: Onur Baser, et al.
Published: (2024-09-01)

Nonalcoholic Steatohepatitis: More Than Just Being Fat
by: Eldon A Shaffer
Published: (2002-01-01)

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
by: Yasuka Matsunaga, et al.
Published: (2015-01-01)

Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests
by: Jesse Fishman, et al.
Published: (2024-02-01)

The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis
by: Vajiheh Rangboo, et al.
Published: (2016-01-01)

Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction
by: Subhra Karmakar, et al.
Published: (2011-01-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis
by: Daniela Cabibi, et al.
Published: (2015-01-01)

Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Yunfei Wu, et al.
Published: (2025-02-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare
by: Andreas Kroh, et al.
Published: (2020-01-01)

Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments
by: Beihui He, et al.
Published: (2022-01-01)

CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis
by: Jingyuan Zhang, et al.
Published: (2025-01-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
by: A. A. Driga, et al.
Published: (2010-11-01)

The AMPK–mTOR Pathway Is Inhibited by Chaihu Shugan Powder, Which Relieves Nonalcoholic Steatohepatitis by Suppressing Autophagic Ferroptosis
by: Zheng Liang, et al.
Published: (2024-01-01)

Differential Expression Profiles of mRNA and Noncoding RNA and Analysis of Competitive Endogenous RNA Regulatory Networks in Nonalcoholic Steatohepatitis
by: Mengjia Gao, et al.
Published: (2022-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
by: Jun Hu, et al.
Published: (2022-01-01)

Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
by: Charles H. Halsted, et al.
Published: (2012-01-01)

Nonalcoholic Fatty Hepatitis: An Important Clinical Condition
by: Samuel W. French, et al.
Published: (1989-01-01)

Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
by: Fan Zhang, et al.
Published: (2025-01-01)

Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
by: Michele Barone, et al.
Published: (2015-01-01)

Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis
by: Nikolina Canová, et al.
Published: (2025-02-01)

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
by: Yuta Hirata, et al.
Published: (2024-12-01)

A Case of Chronic Calcific Nonalcoholic Pancreatitis
by: Aaron Kangas-Dick, et al.
Published: (2016-01-01)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease
by: Doaa H. Hegazy, et al.
Published: (2024-06-01)

Hepatic Abscess due to Burkholderia (Pseudomonas) cepacia in Cystic Fibrosis
by: Kristin L Fraser, et al.
Published: (1995-01-01)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
by: Giuseppina Palladini, et al.
Published: (2019-01-01)

Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
by: Guanghui Ma, et al.
Published: (2025-01-01)

Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease
by: Kadir Ozturk, et al.
Published: (2016-01-01)

Cell Signals Influencing Hepatic Fibrosis
by: Min Cong, et al.
Published: (2012-01-01)